Prediction of S-1 adjuvant chemotherapy benefit in Stage II/III gastric cancer treatment based on comprehensive gene expression analysis

被引：0
|
作者：
Kenichi Nakamura
Keiichi Hatakeyama
Kenichiro Furukawa
Keiichi Fujiya
Satoshi Kamiya
Makoto Hikage
Yutaka Tanizawa
Etsuro Bando
Keiichi Ohshima
Kenichi Urakami
Nozomu Machida
Hirofumi Yasui
Ken Yamaguchi
Masanori Terashima
机构：
[1] Shizuoka Cancer Center,Division of Gastric Surgery
[2] Shizuoka Cancer Center,Medical Genetics Division, Research Institute
[3] Shizuoka Cancer Center,Cancer Diagnostics Research Division, Research Institute
[4] Shizuoka Cancer Center,Division of Gastrointestinal Oncology
[5] Shizuoka Cancer Center,Research Institute
来源：
Gastric Cancer | 2020年 / 23卷
关键词：
Adjuvant drug therapy; Gastric cancer; Drug response biomarker; Gene expression profiling;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：648 / 658
页数：10
相关论文
共 50 条
  • [31] Elderly patients with stage II gastric cancer do not benefit from adjuvant chemotherapy
    Guo, Jianping
    Xiong, Zhizhong
    Yin, Shi
    Wen, Yue'e
    Jin, Longyang
    Wang, Caiqin
    Chen, Huaxian
    Luo, Dandong
    Deng, Zijian
    Huang, Dayin
    Li, Xianzhe
    Yi, Biying
    Mao, Chaobin
    Lian, Lei
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2023, 21 (01)
  • [32] Elderly patients with stage II gastric cancer do not benefit from adjuvant chemotherapy
    Jianping Guo
    Zhizhong Xiong
    Shi Yin
    Yue’e Wen
    Longyang Jin
    Caiqin Wang
    Huaxian Chen
    Dandong Luo
    Zijian Deng
    Dayin Huang
    Xianzhe Li
    Biying Yi
    Chaobin Mao
    Lei Lian
    World Journal of Surgical Oncology, 21
  • [33] Preoperative low skeletal muscle volume can result in insufficient administration of S-1 adjuvant chemotherapy in older patients with stage II/III gastric cancer
    Yusuke Kono
    Tomoyuki Matsunaga
    Masahiro Makinoya
    Shota Shimizu
    Yuji Shishido
    Kozo Miyatani
    Kyoichi Kihara
    Manabu Yamamoto
    Shuichi Takano
    Naruo Tokuyasu
    Teruhisa Sakamoto
    Toshimichi Hasegawa
    Yoshiyuki Fujiwara
    Surgery Today, 2024, 54 : 340 - 346
  • [34] Facilitated completion of 1-year adjuvant S-1 monotherapy for pathological stage II or III gastric cancer by medical oncologists
    Kano, Yosuke
    Ohashi, Manabu
    Hiki, Naoki
    Takahari, Daisuke
    Chin, Keisho
    Yamaguchi, Kensei
    Ida, Satoshi
    Kumagai, Koshi
    Sano, Takeshi
    Nunobe, Souya
    SURGERY TODAY, 2020, 50 (10) : 1197 - 1205
  • [35] Preoperative low skeletal muscle volume can result in insufficient administration of S-1 adjuvant chemotherapy in older patients with stage II/III gastric cancer
    Kono, Yusuke
    Matsunaga, Tomoyuki
    Makinoya, Masahiro
    Shimizu, Shota
    Shishido, Yuji
    Miyatani, Kozo
    Kihara, Kyoichi
    Yamamoto, Manabu
    Takano, Shuichi
    Tokuyasu, Naruo
    Sakamoto, Teruhisa
    Hasegawa, Toshimichi
    Fujiwara, Yoshiyuki
    SURGERY TODAY, 2024, 54 (04) : 340 - 346
  • [36] Phase II Study of Neoadjuvant Chemotherapy With S-1 and CDDP in Patients With Lymph Node Metastatic Stage II or III Gastric Cancer
    Kochi, Mitsugu
    Fuji, Masashi
    Kanamori, Noriaki
    Mihara, Yoshiaki
    Funada, Tomoya
    Tamegai, Hidenori
    Watanabe, Megumu
    Takayama, Yuriko
    Suda, Hiroshi
    Takayama, Tadatoshi
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2017, 40 (01): : 17 - 21
  • [37] Facilitated completion of 1-year adjuvant S-1 monotherapy for pathological stage II or III gastric cancer by medical oncologists
    Yosuke Kano
    Manabu Ohashi
    Naoki Hiki
    Daisuke Takahari
    Keisho Chin
    Kensei Yamaguchi
    Satoshi Ida
    Koshi Kumagai
    Takeshi Sano
    Souya Nunobe
    Surgery Today, 2020, 50 : 1197 - 1205
  • [38] Risk Factors for Peritoneal Recurrence in Stage II/III Gastric Cancer Patients Who Received S-1 Adjuvant Chemotherapy After D2 Gastrectomy
    Toru Aoyama
    Takaki Yoshikawa
    Tsutomu Hayashi
    Hiroshi Kuwabara
    Yo Mikayama
    Takashi Ogata
    Haruhiko Cho
    Akira Tsuburaya
    Annals of Surgical Oncology, 2012, 19 : 1568 - 1574
  • [39] Feasibility study of adjuvant chemotherapy with S-1 plus cisplatin for gastric cancer
    Takahari, D.
    Hamaguchi, T.
    Yoshimura, K.
    Katai, H.
    Ito, S.
    Fuse, N.
    Kinoshita, T.
    Yasui, H.
    Terashima, M.
    Goto, M.
    Tanigawa, N.
    Shirao, K.
    Sano, T.
    Sasako, M.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 67 (06) : 1423 - 1428
  • [40] Evaluation of the optimal dosage of S-1 in adjuvant SOX chemotherapy for gastric cancer
    Yang, Lin
    Yang, Yi
    Qin, Qiong
    Zhou, Aiping
    Zhao, Jianjun
    Wang, Jinwan
    Shu, Chang
    Yuan, Xinghua
    Hu, Songnian
    ONCOLOGY LETTERS, 2015, 9 (03) : 1451 - 1457
12345